Safety, Tolerability and Efficacy of PfSPZ-LARC2 Vaccine Against CHMI in Malaria-Naïve Adults

Clinical trial NCT06862453 · RECRUITING

Trial details

NCT number: NCT06862453
Sponsor: Sanaria Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Malaria Falciparum

Start date: 2026-03-12
Primary completion: 2026-09-30
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.